Title of article
Endothelial Cell Influence on Fibrinolysis
Author/Authors
S. Handt، نويسنده , , Martina Meth، نويسنده , , L. Tietze، نويسنده , , W. G. Jerome، نويسنده , , R. R. Hantgan، نويسنده , , C. Mittermayer، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 1996
Pages
1
From page
397
To page
397
Abstract
Endothelial cells (EC) actively participate in many physiologic processes like inflammation, coagulation and fibrinolysis. EC influence fibrinolysis in both directions, pro- and antifibrinolytic, by secretion of tissue Plasminogen Activator (t-PA) and its antagonist Plasminogen Activator Inhibitor 1 (PAI-1). To understand the role of EC in the situation of a fresh occlusive thrombus, which is i.e. the reason for a myocardial infarction, we developed an in-vitro model with a glass tube, coated with a confluent monolayer of HUVEC (human umbilical venous endothelial cells). In the presence of differently stimulated EC (TNF-α, TGF-β, PMA and Forskolin) a fibrin clot was formed by adding thrombin to a mixture of fibrinogen and plasminogen in a HEPES buffered Geyʹs salt solution. After intervals of 2 and 4 hours the clot was slowly perfused with a buffer solution additionally containing t-PA to induce lysis. Thrombus growth and lysis were measured by laser light scattering and lysis times were determined. In parallel the clots were stained for PAI-1 and analyzed by intermediate voltage electronmicroscopy (IVEM).
We found that cytokine-activated EC strongly delay t-PA induced lysis of a fibrin clot by secreting active PAI-1, which is bound to the fibrin strands. Therefore EC seem to be a major reason for “time dependent thrombolytic resistance”, a term used to describe the reduced sufficiency of thrombolytic therapy starting more than 6 hours after the onset of the symptoms of a myocardial infarction.
Additionally we present data about the behaviour of EC from different vascular beds and show EC morphology and behaviour under the fibrin clot.
Journal title
Biomedicine and Pharmacotherapy
Serial Year
1996
Journal title
Biomedicine and Pharmacotherapy
Record number
476744
Link To Document